期刊文献+

肠道病毒71型在Cellspin系统中无血清微载体培养工艺的建立 被引量:1

Development of culture procedure of enterovirus 71 in Vero cells with serum-free medium on microcarriers using a Cellspin cell cultivation system
原文传递
导出
摘要 目的建立肠道病毒71型(Enterovirus71,EV71)在Cellspin系统中无血清微载体培养工艺,为生物反应器培养EV71工艺的建立奠定基础。方法在Cellspin培养系统中对Vero细胞进行微载体培养,考察不同种类培养基MEM、DMEM/F12、VP-SFM、Opti-SFM、Opti-pro、MD505-199及不同微载体浓度3、5、10 g/L对细胞密度的影响。分别以MOI为0.2及2.0接种EV71至Vero细胞,考察病毒接种量对病毒增殖的影响。分别按培养上清、微载体洗脱液模式收毒,比较不同组分中EV71的抗原含量及TCID50。结果采用5 g/L微载体、VP-SFM培养基时,Vero细胞的密度达4.40×106个/ml;按MOI为2.0染毒,72 h后即可收毒,较MOI为0.2的收毒时间早48 h,按MOI为0.2染毒,收获液上清中的抗原含量达193.5 U/ml,病毒滴度达8.43 Log10TCID50/ml;按上清加洗脱液模式收毒,抗原含量可达573 U/ml。结论成功建立了无血清微载体培养Vero细胞生产EV71的方法,为生物反应器培养EV71工艺的建立奠定了基础。 Objective To develop a procedure for serum-free culture of enterovirus 71 (EV71) in Vero cells on microcarriers using a Cellspin cell cultivation system. Methods Vero cells were cultured on microcarriers in Cellspin cultivation system, based on which the effects of various media (MEM, DMEM/F12, VP-SFM, Opti-SFM, Opti-pro and MD505-199) and concentrations of mierocarriers (3, 5 and 10 g/L) on cell density were investigated. EV71 was inoculated onto Vero cells at MOIs of O. 2 and 2. 0 respectively, and the effect of MOI on virus proliferation was evaluated. The harvested virus liquid was pooled into three fractions as supernatant, wash and eluate, in which the antigen contents and TCIDs0 were compared. Results By using 5 g/L microcarriers and VP-SFM, the density of Vero cells reached 4. 4 x 106 cells / ml. The harvest time of EV71 inoculated at a MOI of 2. 0 was 72 h, which was 48 h ear/ier than that at a MOI of O. 2. However, the antigen content in harvested supernatant of EV71 inoculated at a MOI of 0. 2 reached 193 U/ml, while the virus titer reached 8. 43 Logl0TCID50/ml. The antigen content in EV71 harvested by combining the supernatant and the eluate factions reached 573 U/ml. Conclusion A method for production of EV71 by serum-free culture of Vero cells on microcarriers was developed, which laid a foundation of development of ero ceils by using a Cellspin cell cultivation system was developed, which laid a foundation of development of a procedure for culture of EV71 by bioreaetor.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第3期411-415,共5页 Chinese Journal of Biologicals
关键词 肠道病毒属 培养基 无血清 微载体 悬浮培养 Enterovirus Medium, serum-free Microcarrier Suspension culture
  • 相关文献

参考文献15

  • 1杨俊杰,李薇,王玉琳.肠道病毒71型及其疫苗的研究进展[J].微生物学免疫学进展,2011,39(2):51-56. 被引量:6
  • 2Chou AH, Liu CC, Chang CP, et ol. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates [Jl. PLoS One, 2012, 7 (4): e34834. 被引量:1
  • 3Brunner D, FrankJ, Appl H, et ol. Serum-free cell culture: the serum-free media interactive online database [J]. ALTEX, 2010, 27 (1): 53-62. 被引量:1
  • 4Kistner 0, Barrett PN, Mundt W, et al. Development of a mammalian cell (Vero ) derived candidate influenza virus vaccine [Jl. Vaccine, 1998, 16 (9-10): 960-968. 被引量:1
  • 5Wu SC, Hsieh WC, Liau MY. Comparisons of microcarrier cell culture processes in one hundred mini-liter spinner flask and fifteen-liter bioreactor cultures [J]. Biopro Engi, 1998, 19 (6): 431-434. 被引量:1
  • 6Van Der ValkJ, Brunner D, De Smet K, et ol. Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods [J]. Toxicol In Vitro, 2010, 24 (4): 1053-1063. 被引量:1
  • 7张韧.走自主创新之路 提高我国细胞工程疫苗生产技术水平[J].中国医药生物技术,2006,1(1):72-74. 被引量:1
  • 8PietrzykJ J, WysockiJ, PejczJ, et al. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in com?parison to DTaP-IPV (Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3. 5, 5 and 16 months of age [J]. Vaccine, 2008, 26 (41): 5296-5303. 被引量:1
  • 9Rourou S, Van Der Ark A, Van Der Velden T, et al. Deve?lopment of an animal-component free medium for vero cells culture [J]. Biotechnol Prog, 2009, 25 (6): 1752-1761. 被引量:1
  • 10Rourou S, Van Der Ark A, Van Der Velden T, et al. A micro?carrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions [J]. Vaccine, 2007, 25 (19): 3879-3889. 被引量:1

二级参考文献43

  • 1Haiyang Yu,Wei Chen,Hongwei Chang,Renshu Tang,Jun Zhao,Lin Gan,Boyu Liu,Jason Chen,Mingli Wang.Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008[J]. Virus Genes . 2010 (1) 被引量:1
  • 2Sabine Diedrich,Anna Weinbrecht,Eckart Schreier.Seroprevalence and molecular epidemiology of enterovirus 71 in Germany[J]. Archives of Virology . 2009 (7) 被引量:1
  • 3L. J. Herrero,C. S. M. Lee,R. J. Hurrelbrink,B. H. Chua,K. B. Chua,P. C. McMinn.Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997–2000[J]. Archives of Virology . 2003 (7) 被引量:1
  • 4Tom Solomon,Penny Lewthwaite.Virology,epidemiology,patho-genesis,and control ofEnterovirus71. The Lancet Infectious Diseases . 2010 被引量:1
  • 5Hung KY,Lin TY.Enterovirus71 infection and prevention. Taiwan Epidemiol bulletin . 2008 被引量:1
  • 6http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjby-fkzj/s3578/201102/50646.htm . 被引量:1
  • 7Zhang Y,Tan XJ.An outbreak of hand,foot,and mouth diseaseassociated with subgenotype C4 of humanEnterovirus71 in Shan-dong,China. Journal of Clinical Virology . 2009 被引量:1
  • 8Chen XM,Zhang Q,Li JH,et al.Analysis of recombination andnatural selection in humanEnterovirus71. Journal of Virology . 2010 被引量:1
  • 9Wang JR,Tuan YC,Tsai HP,et al.Change of major genotypeofEnterovirus71 in outbreaks of hand-foot-and-mouth diseasein Taiwan between 1998 and 2000. Journal of Clinical Microbiology . 2002 被引量:1
  • 10Mizuta K,Abiko C,Murata T,et al.Frequent importation ofEnterovirus71 from surrounding countries into the local communi-ty of Yamagata,Japan,between 1998 and 2003. Clin Mcro-biol . 2005 被引量:1

共引文献5

同被引文献11

  • 1郭杨,郭万柱.流行性乙型脑炎病毒及其研究进展[J].预防医学情报杂志,2008,24(1):44-46. 被引量:15
  • 2Jelinek T. Japanese encephalitis vaccine in travelers [J]. Expert Rev Vaccines, 2008, 7(5): 689-693. 被引量:1
  • 3Montagnon BJ, Vincent-Falquet JC. Experience with the Vero cell line [J]. Dev Biol Stand, 1998, 93: 119-123. 被引量:1
  • 4World Health Organization. Requirements for continuous cell lines used for biological substances [J]. WHO Teeh Rep Ser, 1987(745) : 99-115. 被引量:1
  • 5World Health Organization. Requirements for rabies vaccine (inactivated) for human use produced in continuous cell lines I-J]. WHO Teeh Rep Ser, 1987(760) : 167-189. 被引量:1
  • 6国家药典委员会.冻干乙型脑炎灭活疫苗(Veto细胞)[S]//国家药典委员会.中华人民共和国药典2010年版三部.北京:中国医药科技出版社,2010:91-94. 被引量:1
  • 7Merten OW. Safety for vaccine(e)s [J]. Cytotechnology, 2000, 34(3): 181-183. 被引量:1
  • 8Cinatl J Jr, Cinatl J, Rabenau H, et al. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses [J]. Cell Biol Int, 1993, 17(9): 885-895. 被引量:1
  • 9苏晓蕊,岳华,汤承.Vero细胞无血清培养基研究进展[J].动物医学进展,2012,33(2):87-90. 被引量:6
  • 10张晋,马可,白亮,高春龙,苑楠,王红燕,金歌,赵兰英,韩霞.Vero细胞和脊髓灰质炎病毒在无血清条件下的培养探究[J].微生物学免疫学进展,2013,41(5):18-22. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部